With YiduCore as the core, the product application is diversified: the company provides medical solutions based on big data and artificial intelligence (AI) technology. The company provides services and works with key players in the healthcare industry, including hospitals, pharmaceutical, biotechnology and medical device companies, research institutions, insurance companies, doctors and patients, as well as regulators and policy makers. In 2019, the company ranked first among all medical big data solution providers in China, with a market share of 5.0% in China's medical big data solution market.
Medical big data solution emerging markets, the industry is growing rapidly, the prospect is promising: the demand for information, digitization and intelligent synthesis in all areas of the medical industry (including hospitals, regulators, and policy makers, life sciences companies and individuals) continues to deepen with the advent of the big data era. The size of China Healthcare big data solution market (based on the sales volume of health care big data solution service providers) is 10.5 billion yuan in 2019, and is expected to grow to 57.7 billion yuan by 2024, with a compound annual growth rate of 40.5 percent.
Wide range of applications to address the core needs of multiple customers: the company has built a self-developed data intelligent infrastructure, YiduCore, to gain deep insight and knowledge through authorized post-processing and analysis of more than 1.3 billion of timeline medical records from more than 300 million patients, and accordingly developed a set of data analysis-driven medical solutions that can meet the key needs of customers in the medical industry, covering different applications in many fields. Reasonable layout, broad potential for development, to provide services for different participants in the pharmaceutical industry.
Investment advice: business covers big data platform and solutions, life sciences solutions, health management platforms and solutions, with a wide customer base, including hospitals, regulators and policy makers, pharmaceutical, biotechnology and medical device companies, patients and insurance companies. China is currently at the tipping point of a deep improvement of the health care system through the application of massive medical big data. Among them, regulators and policy makers in the life science solution market and medical big data solution market have broad market segmentation prospects, low market penetration and large demand space in the future, and future growth is expected.
The company covers a wide range of products and is rich in application fields. a variety of applications on the same platform for different customers make the company have the opportunity to stand out in different fields and have market potential.